SITC opens calls for nominations for 2022 Steven A. Rosenberg Scholars Award

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

The Society for Immunotherapy of Cancer opened calls for nominations for the Steven A. Rosenberg Scholars Award May 1. This award provides $150,000 in funding to advance the research of an early career scientist in the field of immunology and cancer immunotherapy. 

To access this subscriber-only content please log in or subscribe.

If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.

Login Subscribe
Table of Contents


Iovance Biotherapeutics Inc. a commercial biotechnology company focused on innovating, developing, and delivering novel polyclonal tumor infiltrating lymphocyte therapies for patients with cancer, has updated clinical data for lifileucel in combination with pembrolizumab in frontline advanced melanoma, as well as translational data, for the upcoming 2024 ASCO Annual Meeting.